Loading...
Bevacizumab for the management of diabetic macular edema
Diabetic retinopathy (DR) is a leading cause of vision loss in the working-age population and is relatedto 1%-5% of cases of blindness worldwide. Diabetic macular edema (DME) is the most frequent cause of DR vision loss and is an important public health problem. Recent studies have implicated vascul...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Baishideng Publishing Group Co., Limited
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3627413/ https://ncbi.nlm.nih.gov/pubmed/23593532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v4.i2.19 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|